Oriflame (Sell, TP: SEK331.00) - Focus on Asia & Turkey
Our Q4 revenue estimate is slightly below consensus, while we are c5% below on adjusted EBIT and c8% below on EPS (results due before market open on 15 February). While we expect focus to be on reported figures and on the pace into 2018, we see upside potential on Cetes and downside risk on Asia & Turkey. Based on our valuation, we have downgraded to SELL (HOLD) and reiterate our target price of SEK331.Oriflame Holding AG. Oriflame Holding AG is a Switzerland-based developer, producer and marketer of beauty products. The Company's product portfolio includes skin care products, such as day and night creams, lip care, face treatments and serums and sun protectors, as well as facial brushes, sponges and mirrors; color cosmetics, such as lipstick, brushes, nail polish, eye make-up, eye make-up remover and powder; fragrances, including deodorants and perfume; personal and hair care products, such as shampoo, styling products, shower gel and oral care products; accessories, including bags, gloves, hats, sunglasses, watches, rings, necklaces, bracelets and scarves, and wellness products, such as soups, shakes and nutrition products.
DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.